An European Organisation for Research and Treatment of Cancer phase I study of lapatinib and docetaxel as neoadjuvant treatment for Human Epidermal Growth Factor Receptor 2 (HER2) positive locally-advanced/inflammatory or large operable breast cancer

Nom du journal : Eur J Cancer

Année : 2013

Volume : 49

Page de départ : 281

Page de fin : 289

Auteurs: Bonnefoi H, Zaman K, Debled M, Fiche M, Fournier M, Nobahar M, Pierga JY, Koch KM, Bartlett J, Zimmer A, Marréaud S, Bogaerts J, Cameron D, Zimmer A,